Evidence map›Paper›PMID 22206924›Full record

ArticleExperimental neurology2012

Calcium dependence of damage to mouse motor nerve terminals following oxygen/glucose deprivation.

Janet D Talbot, Gavriel David, Ellen F Barrett, John N Barrett

Abstract read
In one paragraph

Article in Experimental neurology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Janet D TalbotDepartment of Physiology and Biophysics, University of Miami Miller School of Medicine, P.O. Box 016430, Miami, FL 33101, USA. jtalbot@med.miami.edu
Gavriel David
Ellen F Barrett
John N Barrett

Funding

Ca2+ mishandling and ischemia-vulnerability in fALS model motor terminalsR01NS058888 · NINDS · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI DAVID, GAVRIEL · 2008 to 2012
$1.4M
NINDS NIH HHS R01 NS058888NINDS NIH HHS R01NS 58888
6 · The paper itself

Abstract

Motor nerve terminals are especially sensitive to an ischemia/reperfusion stress. We applied an in vitro model of this stress, oxygen/glucose deprivation (OGD), to mouse neuromuscular preparations to investigate how Ca(2+) contributes to stress-induced motor terminal damage. Measurements using an ionophoretically-injected fluorescent [Ca(2+)] indicator demonstrated an increase in intra-terminal [Ca(2+)] following OGD onset. When OGD was terminated within 20-30min of the increase in resting [Ca(2+)], these changes were sometimes reversible; in other cases [Ca(2+)] remained high and the terminal degenerated. Endplate innervation was assessed morphometrically following 22min OGD and 120min reoxygenation (32.5°C). Stress-induced motor terminal degeneration was Ca(2+)-dependent. Median post-stress endplate occupancy was only 26% when the bath contained the normal 1.8mM Ca(2+), but increased to 81% when Ca(2+) was absent. Removal of Ca(2+) only during OGD was more protective than removal of Ca(2+) only during reoxygenation. Post-stress endplate occupancy was partially preserved by pharmacological inhibition of various routes of Ca(2+) entry into motor terminals, including voltage-dependent Ca(2+) channels (ω-agatoxin-IVA, nimodipine) and the plasma membrane Na(+)/Ca(2+) exchanger (KB-R7943). Inhibition of a Ca(2+)-dependent protease with calpain inhibitor VI was also protective. These results suggest that most of the OGD-induced motor terminal damage is Ca(2+)-dependent, and that inhibition of Ca(2+) entry or Ca(2+)-dependent proteolysis can reduce this damage. There was no significant difference between the response of wild-type and presymptomatic superoxide dismutase 1 G93A mutant terminals to OGD, or in their response to the protective effect of the tested drugs.

Indexed as

AnimalsBacterial ProteinsBungarotoxinsCalciumDisease Models, AnimalEgtazic AcidEnzyme InhibitorsGlucoseHumansHypoxiaIn Vitro TechniquesLuminescent ProteinsMembrane Potential, MitochondrialMiceMice, Inbred C57BLMice, Transgenic1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid2-(2-(4-(4-nitrobenzyloxy)phenyl)ethyl)isothiourea methanesulfonateBacterial ProteinsBungarotoxinsCalciumEgtazic AcidEnzyme InhibitorsGlucoseLuminescent ProteinsSOD1 G93A proteinSuperoxide DismutaseThioureayellow fluorescent protein, Bacteria

Identifiers

PMID22206924
PMCPMC3673770

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.